deltatrials
Completed OBSERVATIONAL NCT01419327

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan (FOSRENOL-HD)

Special Drug Use Investigation of Fosrenol (Long-term Investigation for Patients With Hemodialysis)

Sponsor: Bayer

Conditions Hyperphosphatemia
Interventions Lanthanum Carbonate (Fosrenol, BAY77-1931) - chewable tablet
Updated 24 times since 2017 Last updated: May 18, 2020 Started: Mar 23, 2009 Primary completion: Jan 30, 2019 Completion: May 28, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hyperphosphatemia and is currently completed. Bayer leads this study, which shows 24 recorded versions since 2009 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jul 2017 · 6 months · monthly snapshot~Jul 2017 – ~Dec 2017 · 5 months · monthly snapshot~Dec 2017 – ~Apr 2018 · 4 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Jun 2020 · 9 months · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

24 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2020 — Jan 2021 [monthly]

    Completed

  5. Sep 2019 — Jun 2020 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

▶ Show 19 earlier versions

  1. Aug 2019 — Sep 2019 [monthly]

    Active Not Recruiting

  2. Jul 2019 — Aug 2019 [monthly]

    Active Not Recruiting

  3. Jun 2019 — Jul 2019 [monthly]

    Active Not Recruiting

  4. May 2019 — Jun 2019 [monthly]

    Active Not Recruiting

  5. Apr 2019 — May 2019 [monthly]

    Active Not Recruiting

  6. Mar 2019 — Apr 2019 [monthly]

    Active Not Recruiting

  7. Feb 2019 — Mar 2019 [monthly]

    Active Not Recruiting

  8. Jan 2019 — Feb 2019 [monthly]

    Active Not Recruiting

  9. Dec 2018 — Jan 2019 [monthly]

    Active Not Recruiting

  10. Nov 2018 — Dec 2018 [monthly]

    Active Not Recruiting

  11. Oct 2018 — Nov 2018 [monthly]

    Active Not Recruiting

  12. Sep 2018 — Oct 2018 [monthly]

    Active Not Recruiting

  13. Aug 2018 — Sep 2018 [monthly]

    Active Not Recruiting

  14. Jul 2018 — Aug 2018 [monthly]

    Active Not Recruiting

  15. Jun 2018 — Jul 2018 [monthly]

    Active Not Recruiting

  16. Apr 2018 — Jun 2018 [monthly]

    Active Not Recruiting

    Phase: NA → None

  17. Dec 2017 — Apr 2018 [monthly]

    Active Not Recruiting NA

  18. Jul 2017 — Dec 2017 [monthly]

    Active Not Recruiting NA

  19. Jan 2017 — Jul 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bayer
Data source: Bayer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations